Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Tax Rate (2018 - 2025)

Historic Tax Rate for Ani Pharmaceuticals (ANIP) over the last 14 years, with Q3 2025 value amounting to 21.3%.

  • Ani Pharmaceuticals' Tax Rate fell 19800.0% to 21.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.82%, marking a year-over-year increase of 143300.0%. This contributed to the annual value of 16.61% for FY2024, which is 111100.0% up from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Tax Rate is 21.3%, which was down 19800.0% from 19.0% recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Tax Rate high stood at 37.87% for Q3 2021, and its period low was 21.96% during Q4 2023.
  • Its 5-year average for Tax Rate is 17.49%, with a median of 22.0% in 2021.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Tax Rate soared by 6727900bps in 2021, and later crashed by -476100bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Tax Rate (Quarter) stood at 21.77% in 2021, then increased by 18bps to 25.65% in 2022, then crashed by -186bps to 21.96% in 2023, then surged by 215bps to 25.33% in 2024, then dropped by -16bps to 21.3% in 2025.
  • Its Tax Rate stands at 21.3% for Q3 2025, versus 19.0% for Q2 2025 and 21.54% for Q1 2025.